In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system investigates the multifaceted implementation of pharmacogenomics—a rapidly evolving ...

The application of pharmacogenomics to infectious diseases is in its infancy. The mapping of the human genome was completed in June 2000.

Understanding the challenges and opportunities in transitioning to IVDR for pharmacogenomics can be complex. Learn more about how to overcome these challenges effectively.

Our Pharmacogenomics and Transport micro-credential is a three-course series encompassing several aspects of pharmacogenomics from transport to current events incorporating cancer and nutrition. Each ...

This comprehensive pharmacogenomics eBook was curated for you to gain valuable knowledge and insights into the rapidly advancing field of precision medicine. This eBook focuses on three key areas: ...

As the industry moves towards more personalized medicine, pharmacogenomics could play a key role in keeping patients healthier longer and in getting them viable treatments for their unique genetic ...

Pharmacogenomics is transforming precision medicine, enabling treatments tailored to individual genetic profiles. By bridging genetic insights and therapeutic applications, this field is helping ...

Pharmacogenomics--the application of genotyping to patient therapy--could revolutionize drug discovery and medical treatment. Side effects plague most prescription drugs--often, some percentage of ...

Despite mounting evidence of clinical and economic utility, barriers still exist for the implementation of pharmacogenomics as standard of care. The webinar will address these topics and others to ...